P08.03 In-vivo DCE-MRI for the discrimination between glioblastoma and radiation necrosis in rats

Por Bolcaen, J., Descamps, B., Acou, M., Deblaere, K., Van den Broecke, C., Boterberg, T., Vanhove, C., Goethals, I.
Publicado no Neuro Oncol (2017)

P04.83 Additive effect of tonabersat on standard medical treatment in glioblastoma: preliminary results

Por de Meulenaere, V, Bonte, E, Verhoeven, J, Kalala Okito, J, Leybaert, L, Vanhove, C, Descamps, B, Deblaere, K
Publicado no Neuro Oncol (2018)

P07.22 Kinetic modeling and graphical analysis of 18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET) and 18F-fluorodeoxyglucose (FDG) PET for the discrimination between...

Por Bolcaen, J., Lybaert, K., Moerman, L., Descamps, B., Deblaere, K., Boterberg, T., Kalala, J., De Vos, F., Vanhove, C., Goethals, I.
Publicado no Neuro Oncol (2016)

P04.82 [(18)F]-FET and [(18)F]-FAZA PET based radiotherapy of F98 glioblastoma rats

Por Verhoeven, J, Bolcaen, J, Donche, S, de Meulenaere, V, Descamps, B, Hallaert, G, Kersemans, K, Boterberg, T, Vanhove, C, de Vos, F, Goethals, I
Publicado no Neuro Oncol (2018)

P04.26 In vitro and in vivo evaluation of the LAT1 PET tracer 2-[(18)F]FELP in comparison to [(18)F]FET and [(18)F]FDG

Por Verhoeven, J., Bolcaen, J., Kersemans, K., De Meulenaere, V., Deblaere, K., Kalala, J., Van den Broecke, C., Vanhove, C., Goethals, I., De Vos, F.
Publicado no Neuro Oncol (2017)